Innoviz Technologies Ltd. (INVZ) is an Israel-based supplier of automotive-grade solid-state LiDAR sensors and perception software used in autonomous vehicles, robotics, industrial equipment, and — increasingly — defense and homeland security applications marketed under its Perciz brand. The stock was trading at $0.123 on Thursday morning, a decline of 15.00% from the previous session's close of $0.1447. The direction is unambiguously lower. The immediate cause is verifiable: after Wednesday's close, Innoviz confirmed it will consolidate its share count at a 1-for-20 ratio, the maximum approved by shareholders in September, in order to push its per-share price back above Nasdaq's minimum bid threshold.
The mechanics are simple, but the market read them as a signal rather than housekeeping. Innoviz will reduce outstanding ordinary shares from approximately 299.5 million to roughly 15 million, effective at 11:59 p.m. Eastern on Friday, December 4, 2026. Shares begin trading split-adjusted at the Nasdaq open on Monday, December 7, under the same INVZ symbol but a new CUSIP, M5R635 124. Authorized share capital drops proportionately from 500 million to 25 million shares.
Reverse splits do not change ownership percentages, but they frequently advertise distress — and the company chose the widest ratio available. Innoviz also acknowledged there is no assurance the maneuver restores compliance. For a stock already trading near triple-digit year-to-date losses, the announcement converted an abstract listing risk into a dated deadline, and sellers responded in the pre-market. The shares opened at $0.113, traded as low as the same level in the first minutes, and have since recovered modestly toward $0.12.
The split did not arrive in a vacuum. On November 11, Innoviz reported third-quarter revenue of $12.1 million against expectations near $18.9 million, with a gross margin of negative 10.3% and an operating loss of $20.9 million. Management attributed much of the shortfall to a customer pushing its start-of-production timing into 2027, shifting a large block of NRE revenue out of 2026. Full-year revenue guidance now sits at $44 million to $46 million.
The cost response was concrete — a roughly 20% workforce reduction targeting $17.5 million in annualized savings, with the company pointing to a runway into 2028 on $54.4 million of cash and no long-term debt. But the defense narrative, while promising, has not yet produced volume orders. JPMorgan cut the stock to Neutral from Overweight on November 12, adding a second layer of institutional caution. Together, these factors set up a shareholder base with little tolerance for further balance-sheet optics.
Volume was heavy at the open: roughly 600,000 shares changed hands in the first ten minutes, a pace well above the roughly 3 million shares the stock averages in a full session. The selling was concentrated in the opening rotation rather than spread evenly, a pattern typical of headlines digested before the bell.
The move was idiosyncratic. No sector-wide LiDAR or automotive-technology catalyst explains a 15% gap lower, and the decline is not a reflection of broad index direction. Technically, the stock broke below the November 11 low of $0.1343 to print a fresh low for the year at $0.113, and it remains far beneath its short- and long-term moving averages, with the trend firmly negative. For the year, the shares have lost roughly 79% of their value.
The scale runs from 0, meaning no meaningful news and an ordinary move for the stock, to 100, meaning transformative news and an extreme, rare price move. This event scores 44 out of 100.
The verified news is moderate rather than transformative: a defensive listing-compliance action with no new capital raised, no confirmed commercial win, and no change to the underlying business. The price behavior is unusually sharp but not unprecedented — Thursday's 15.00% decline is about 3.8 times the stock's typical daily move of roughly 4% over the last 60 sessions, and a move of that magnitude has occurred only twice in that window. Two solid but unexceptional components combine into a mid-range score.
The calendar now dominates. Investors will watch the December 4 effective date and the December 7 debut of split-adjusted trading, when the shares should open near $2.40 on a consolidated basis. Holding above $1.00 afterward is the compliance test that matters. Before that, the company's fourth-quarter and full-year 2026 results — expected in the first quarter of 2027 — will be the first real check on whether the $44 million to $46 million revenue target and the cost realignment were delivered.
Key variables include the timing of deferred NRE payments, the conversion of Perciz defense discussions into volume orders, cash burn against the $54.4 million balance, and whether additional financing is required. Analyst coverage remains thin, with a Hold consensus and wide dispersion in expectations. The principal risks are execution delays, further customer program slippage, and the possibility that the split fails to sustain a compliant price.
Tickeron's Trending AI Robots page is a curated window into that library: hundreds of AI trading bots covering thousands of tickers, with only the strongest performers under current market conditions surfaced for review. Bots differ widely by strategy, timeframe, performance metrics, and the symbols they trade, so the featured list changes as conditions shift. Readers researching volatile names like INVZ can use it as a starting point for comparing approaches.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Financial writer and active order flow futures trader with a focus on fundamental analysis, macroeconomic factors, and equity research. I make in-depth blogs on stocks and ETFs, bridging the gap between raw market data and real-world trading decisions.
INVZ may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In 38 of 42 cases where INVZ's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are 90%.
The RSI Indicator shows that the ticker has stayed in the oversold zone for 5 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an Uptrend is expected.
The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 3 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.
Following a +13.50% 3-day Advance, the price is estimated to grow further. Considering data from situations where INVZ advanced for three days, in 188 of 224 cases, the price rose further within the following month. The odds of a continued upward trend are 84%.
The Momentum Indicator moved below the 0 level on November 10, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on INVZ as a result. In 65 of 74 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 88%.
The Moving Average Convergence Divergence Histogram (MACD) for INVZ turned negative on November 13, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 43 similar instances when the indicator turned negative. In 38 of the 43 cases the stock turned lower in the days that followed. This puts the odds of success at 88%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where INVZ declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 90%.
The Aroon Indicator for INVZ entered a downward trend on November 20, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron PE Growth Rating for this company is 8 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of 29 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.285) is normal, around the industry mean (0.781). P/E Ratio (-0.553) is within average values for comparable stocks, (39.881). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.494). Dividend Yield (0.000) settles around the average of (0.043) among similar stocks. P/S Ratio (1.236) is also within normal values, averaging (49.456).
The Tickeron Seasonality Score of 85 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Price Growth Rating for this company is 96 (best 1 - 100 worst), indicating slightly worse than average price growth. INVZ’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 99 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. INVZ’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 91, placing this stock worse than average.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Industry AutoPartsOEM